| Bioactivity | PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9. PCSK9-IN-22 inhibits the interaction of the protein with LDLR in vivo[1]. |
| Name | PCSK9-IN-22 |
| CAS | 2794203-47-5 |
| Formula | C28H30N6O |
| Molar Mass | 466.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Phillip Albert Coghlan, et al. Heterocyclic inhibitors of pcsk9. WO2022133529A1. 2022-06-30. |
PCSK9-IN-22
CAS: 2794203-47-5 F: C28H30N6O W: 466.58
PCSK9-IN-22 (compound 29) is an orally active inhibitor of PCSK9. PCSK9-IN-22 inhibits the interaction of the protein wi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.